NM_000096.4:c.1948G>A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PP3_StrongPP5_Very_Strong
The NM_000096.4(CP):c.1948G>A(p.Gly650Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. G650G) has been classified as Benign.
Frequency
Consequence
NM_000096.4 missense
Scores
Clinical Significance
Conservation
Publications
- aceruloplasminemiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- disorder of iron metabolism and transportInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152134Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251418 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727238 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74318 show subpopulations
ClinVar
Submissions by phenotype
Deficiency of ferroxidase Pathogenic:3
- -
The p.Gly650Arg variant (also reported as p.Gly631Arg) in CP has been reported in the homozygous state in 1 individual with aceruloplasminemia and segregated with disease in 3 affected siblings (Vroegindeweij 2015 PMID: 25661792). It was also identified in 1/15276 (0.007) Latino/Admixed American chromosomes by gnomAD (https://gnomad.broadinstitute.org/). This variant has also been reported in ClinVar (Variation ID 381716). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In vitro studies suggest that the variant impairs normal protien function (Hellman 2002 PMID: 12351628, di Patti 2009 PMID: 19095659), however, these types of assays may not accurately represent biological function. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive aceruloplasminemia. ACMG/AMP criteria applied: PP1_Strong, PM2_Supporting, PP3, PS3_Supporting. -
This sequence change replaces glycine with arginine at codon 650 of the CP protein (p.Gly650Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has been observed in homozygosis in several individuals affected with hypoceruloplasminemia and to segregate with the disease in a family (PMID: 28012953). This variant is also known as G631R in the literature. ClinVar contains an entry for this variant (Variation ID: 381716). Experimental studies have shown that this missense change prevents the incorporation of copper into the CP protein, abrogating the CP protein enzymatic activity and being unable to rescue CP null cells (PMID: 12351628, 16629161, 19095659). For these reasons, this variant has been classified as Pathogenic. -
Neurodegeneration with brain iron accumulation Pathogenic:1
Variant summary: CP c.1948G>A (p.Gly650Arg) results in a non-conservative amino acid change located in the fourth cupredoxin domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251418 control chromosomes (gnomAD). c.1948G>A has been reported in the literature in multiple individuals affected with Aceruloplasminaemia (Hellman_2002, Di Raimondo_2008, Vroegindeweij_2017). These data indicate that the variant is very likely to be associated with disease. Publications report experimental evidence evaluating an impact on protein function, finding that the variant resulted in the synthesis and secretion only of apoceruloplasmin and prevented incorporation of copper (Hellman_2002, Kono_2006). The following publications have been ascertained in the context of this evaluation (PMID: 12351628, 16629161, 18408989, 28012953). ClinVar contains an entry for this variant (Variation ID: 381716). Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:1
The G650R variant in the CP gene has been reported previously in association with aceruloplasminemia, in an affected individual who was homozygous for the G650R variant (Hellman et al., 2002). The G650R variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The G650R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. Functional studies show the G650R variant is secreted as an inactive apoprotein lacking copper (Hellman et al., 2002; di Patti et al., 2009). The G650R variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at